Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyokazu Sasaki

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|August 30, 2008
Androgens upregulate aquaporin 9 expression in the prostateJianbo Wang, Nozomu Tanji, Toyokazu Sasaki, et al.
Expert Review of Anticancer Therapy|June 29, 2011
Potential of histone deacetylase inhibitors for bladder cancer treatmentNozomu Tanji, Akira Ozawa, Tadahiko Kikugawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 12, 2009
[Intrascrotal rhabdomyosarcoma in adult: a case report]Kenji Shimamoto, Nozomu Tanji, Akira Ozaw, et al.
BJU International|August 18, 2009
Inhibition of bladder tumour growth by histone deacetylase inhibitorAkira Ozawa, Nozomu Tanji, Tadahiko Kikugawa, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
Anti-tumor effect of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cellsKoji Azuma, Koh-ichi Nakashiro, Toyokazu Sasaki, et al.
Oncology Reports|October 20, 2004
Fibroblast growth factor receptor 3 protein expression in urothelial carcinoma of the urinary bladder, exhibiting no association with low-grade and/or non-invasive lesionsManabu Matsumoto, Yuji Ohtsuki, Kenji Ochii, et al.
Biochemical and Biophysical Research Communications|July 28, 2006
Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cellsAkinobu Maeda, Koh-ichi Nakashiro, Shingo Hara, et al.
Anticancer Research|October 15, 2010
Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and overNozomu Tanji, Tetsuya Fukumoto, Noriyoshi Miura, et al.
Histology and Histopathology|September 29, 2012
Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspectsNaoto Kuroda, Azusa Tanaka, Chisato Ohe, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivoToyokazu Sasaki, Koh-Ichi Nakashiro, Hiroshi Tanaka, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Urology : Official Journal of the Japanese Urological Association|August 30, 2008
Androgens upregulate aquaporin 9 expression in the prostateJianbo Wang, Nozomu Tanji, Toyokazu Sasaki, et al.
Expert Review of Anticancer Therapy|June 29, 2011
Potential of histone deacetylase inhibitors for bladder cancer treatmentNozomu Tanji, Akira Ozawa, Tadahiko Kikugawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 12, 2009
[Intrascrotal rhabdomyosarcoma in adult: a case report]Kenji Shimamoto, Nozomu Tanji, Akira Ozaw, et al.
BJU International|August 18, 2009
Inhibition of bladder tumour growth by histone deacetylase inhibitorAkira Ozawa, Nozomu Tanji, Tadahiko Kikugawa, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
Anti-tumor effect of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cellsKoji Azuma, Koh-ichi Nakashiro, Toyokazu Sasaki, et al.
Oncology Reports|October 20, 2004
Fibroblast growth factor receptor 3 protein expression in urothelial carcinoma of the urinary bladder, exhibiting no association with low-grade and/or non-invasive lesionsManabu Matsumoto, Yuji Ohtsuki, Kenji Ochii, et al.
Biochemical and Biophysical Research Communications|July 28, 2006
Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cellsAkinobu Maeda, Koh-ichi Nakashiro, Shingo Hara, et al.
Anticancer Research|October 15, 2010
Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and overNozomu Tanji, Tetsuya Fukumoto, Noriyoshi Miura, et al.
Histology and Histopathology|September 29, 2012
Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspectsNaoto Kuroda, Azusa Tanaka, Chisato Ohe, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivoToyokazu Sasaki, Koh-Ichi Nakashiro, Hiroshi Tanaka, et al.
Pageof 2